Search Labs

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Core Facilities >

Habib Lab

Our laboratory is interested in improving treatment for patients with glioblastoma (GBM) and other cancers. We work on understanding signal transduction pathways involved in the pathogenesis of cancer. Recent work has focused on investigating mechanisms of resistance to targeted treatment in GBM and lung cancer. We are also interested in mechanisms regulating invasion in GBM. 

  • Amyn Habib, M.D.
Cancer Biology

Hancks Lab

We employ a variety of methods including evolutionary analysis, genomics, and molecular biology to study the biology of infection.

  • Dustin Hancks, Ph.D.
genetics of host-virus interfaces
Genetics, Development and Disease Immunology

Hannan Lab

Our goal is to understand and exploit the immunogenic properties of tumor irradiation in integrating it with immunotherapy to improve cancer patient outcome.

  • Raquibul Hannan, M.D., Ph.D.
RCC prostate cancer immunotherapy immunomodulation cancer immunology cancer vaccination SBRT stereotactic radiation genitourinary cancer SAbR Tumor microenvironment DNA sensing
Cancer Biology

Harbour Lab

Dr. Harbour’s research focuses on the use of genetic and genomic technology, cell culture experiments and genetically modified experimental models to understand mechanisms of tumor progression in major forms of eye cancer, including uveal melanoma, retinoblastoma, intraocular lymphoma and others.

  • J. William Harbour, M.D.
uveal melanoma retinoblastoma ocular oncology cancer epigenetics
Cancer Biology

Harris-Tryon Lab

Our focus is on gaining a greater understanding of how bacteria on the skin surface affect skin health and diseases.

  • Tamia Harris-Tryon, M.D., Ph.D.
Skin Microbiota host-pathogen interaction lipids Inflammation Innate Immunity microbiome Immunology

Hattori Lab

The Hattori lab studies how neural circuits integrate sensorimotor information, memory, and internal state to guide behavior.

  • Daisuke Hattori, Ph.D.
Systems Neuroscience

He Lab

The goal of our research lab is to identify the early steps in the pathogenesis of AMD, and to investigate the novel methods to treat and even to prevent its development.

  • Yu-Guang He, M.D.
AMD macular degeneration Retinal degenerative disease

Hendrixson Lab

The Hendrixson Lab is largely focused on exploring the biology of polarly-flagellated bacterial pathogens….and junk food, donuts, and cake.

  • David Hendrixson, Ph.D.
Campylobacter jejuni Flagellar Motility Short-Chain Fatty Acid
Molecular Microbiology

Henkemeyer Lab

The primary goal of Henkemeyer laboratory is to understand the biochemical signals that regulate cell-cell interactions during embryonic development. 

  • Mark Henkemeyer, Ph.D.

Henne Lab

Henne lab is interested in how cells spatially organize their metabolism to adapt to a constantly changing environment.

  • W. Mike Henne, Ph.D. Associate Professor Department of Cell Biology & Department of Biophysics
organelle biology
Cell and Molecular Biology Molecular Biophysics

Henning Lab

The Henning lab develops novel ultra-high field MRI and metabolic MRI methodology for human application and translates it to neuroscientific, physiological and clinical trials in brain, spine, heart and muscle disorders. 

  • Anke Henning, Ph.D.
Biomedical Engineering

Herz Lab

The goal of the Herz Lab is to identify the underlying biochemical principles of human diseases & disorders in order to design novel therapies to prevent, delay, or cure them.

  • Joachim Herz, M.D.

Hilgemann Lab

We do difficult experiments at the frontier of cell physiology, often with our own methods and always with our own hands. Enter a description of the lab. This information will appear on the lab listing page.

  • Donald W. Hilgemann, Ph.D.

Hill Lab

We strive to decipher mechanisms of structural, functional, and electrical remodeling in heart disease with an eye toward therapeutic intervention. 

  • Joseph Hill, M.D., Ph.D.
Cell and Molecular Biology

Hitti Lab

Our lab focuses on investigating the brain circuits implicated in treatment resistant depression with the ultimate goal of developing novel therapies for this devastating disease.

  • Frederick Hitti, M.D., Ph.D.
treatment resistant depression lateral habenula

Hobbs-Cohen Lab

Our research program focuses on understanding how dysregulation of lipid uptake and trafficking contributes to human diseases. 

  • Helen Hobbs, M.D.
  • Jonathan Cohen, Ph.D.
Lipid Metabolism
Genetics, Development and Disease Genetics, Development and Disease

Hon Lab

We explore questions on genomes using a systems biology approach: developing and employing integrative approaches at the interface of gene regulation, epigenetics, single-cell genomics, and bioinformatics.

  • Gary Hon, Ph.D.
Biomedical Engineering Genetics, Development and Disease

Hooper Lab

We are broadly interested in understanding how resident intestinal bacteria influence the biology of humans and other mammalian hosts.

  • Lora Hooper, Ph.D.
Immunology Molecular Microbiology

Horton Lab

A major focus of the Horton lab is to determine how these transcriptional regulators contribute to the development of steatosis in various disease processes such as diabetes, obesity, and beta-oxidation defects. A second area of investigation centers on determining the function of PCSK9, a protein that is involved in determining plasma LDL cholesterol levels through its ability to post-transcriptionally regulate the expression of the LDL receptor in liver.

  • Jay Horton, M.D.
Cell and Molecular Biology

Hoshida Lab

We are multidisciplinary team of clinicians and scientists, focusing on liver cancer risk-predictive molecular biomarkers specific to clinical contexts (ex. geographic region, liver disease etiology, and patient race/ethnicity) individual risk-stratified personalized cancer screening.

  • Yujin Hoshida, M.D., Ph.D.
Cancer Biology

Hoxhaj Lab

 In diseases like cancer, signaling pathways can be corrupted by mutations that cause the cells to grow and spread uncontrollably. Our lab is interested in understanding how these defective pathways reprogram cellular metabolism to drive cancer growth.

  • Gerta Hoxhaj, Ph.D.
Biological Chemistry Cancer Biology

Hsieh (Jer-Tsong) Lab

Jer-Tsong Hsieh Lab research interests focus on key molecular mechanisms leading to urologic cancer progression, development of precision medicine of cancer therapy assisted with non-invasive molecular imaging.

  • JT Hsieh, Ph.D.
Cancer Biology Cell and Molecular Biology

Hu (Ming-Chang) Lab

Ming-Chang Hu Lab strives to offer novel insight into the cellular and molecular mechanisms of AKI progression to CKD and cardiovascular diseases (vascular calcification and uremic cardiomyopathy) development in CKD, and set up a solid basis for preclinical and clinical study in the future.

  • Ming-Chang Hu, M.D., Ph.D.